Cargando…
Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives
Determination of hormone receptor (estrogen receptor and progesterone receptor) and human epidermal growth factor receptor 2 status in the primary tumor is clinically relevant to define breast cancer subtypes, clinical outcome, and the choice of therapy. Retrospective and prospective studies suggest...
Autores principales: | Criscitiello, Carmen, André, Fabrice, Thompson, Alastair M, De Laurentiis, Michele, Esposito, Angela, Gelao, Lucia, Fumagalli, Luca, Locatelli, Marzia, Minchella, Ida, Orsi, Franco, Goldhirsch, Aron, Curigliano, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052940/ https://www.ncbi.nlm.nih.gov/pubmed/25032257 http://dx.doi.org/10.1186/bcr3630 |
Ejemplares similares
-
Best management of locally advanced inoperable breast cancer
por: Curigliano, Giuseppe, et al.
Publicado: (2013) -
Immune approaches to the treatment of breast cancer, around the corner?
por: Criscitiello, Carmen, et al.
Publicado: (2014) -
Tumour dormancy and clinical implications in breast cancer
por: Gelao, L, et al.
Publicado: (2013) -
Immune Checkpoint Blockade in Cancer Treatment: A Double-Edged Sword Cross-Targeting the Host as an “Innocent Bystander”
por: Gelao, Lucia, et al.
Publicado: (2014) -
Impact of autoimmune diseases on outcome of patients with early breast cancer
por: Criscitiello, Carmen, et al.
Publicado: (2016)